0001213900-14-006321.txt : 20140828 0001213900-14-006321.hdr.sgml : 20140828 20140828213604 ACCESSION NUMBER: 0001213900-14-006321 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140826 FILED AS OF DATE: 20140828 DATE AS OF CHANGE: 20140828 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hadjimichael Amalia CENTRAL INDEX KEY: 0001591257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 141073189 MAIL ADDRESS: STREET 1: SIMOU MENARDOU 8, RIA COURT 8 STREET 2: OFFICE 101, 6015 CITY: LARNACA STATE: G4 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hadjimichael Andreas CENTRAL INDEX KEY: 0001591256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 141073190 MAIL ADDRESS: STREET 1: SIMOU MENARDOU 8, RIA COURT 8 STREET 2: OFFICE 101, 6015 CITY: LARNACA STATE: G4 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Czernik Marcin CENTRAL INDEX KEY: 0001591275 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 141073191 MAIL ADDRESS: STREET 1: SIMOU MENARDOU 8, RIA COURT 8 STREET 2: OFFICE 101, 6015 CITY: LARNACA STATE: G4 ZIP: 00000 4 1 f4082514czernik_karyo2.xml OWNERSHIP DOCUMENT X0306 4 2014-08-26 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001591275 Czernik Marcin SIMOU MENARDOU 8, RIA COURT 8, OFFICE 101 6015 LARNACA G4 CYPRUS 0 0 1 0 0001591256 Hadjimichael Andreas SIMOU MENARDOU 8, RIA COURT 8, OFFICE 101 6015 LARNACA G4 CYPRUS 0 0 1 0 0001591257 Hadjimichael Amalia SIMOU MENARDOU 8, RIA COURT 8, OFFICE 101 6015 LARNACA G4 CYPRUS 0 0 1 0 COMMON STOCK 2014-08-26 4 S 0 20393 38.5004 D 3007459 I See Footnotes COMMON STOCK 2014-08-26 4 S 0 1846 39.0926 D 3005613 I See Footnotes COMMON STOCK 2014-08-27 4 S 0 21460 39.0695 D 2984153 I See Footnotes The prices reported in Column 4 are weighted average prices. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the respective ranges set forth in footnotes 2, 3 and 4 below . The shares were sold at prices ranging from $38.01 to $38.95, inclusive. The shares were sold at prices ranging from $39.00 to $39.19, inclusive. The shares were sold at prices ranging from $39.00 to $39.18, inclusive. Shares of Common Stock are owned directly by Plio Limited ("Plio"), which holds less than 10% of the outstanding Common Stock of the issuer. Plio's directors, Marcin Czernik, Andreas Hadjimichael and Amalia Hadjimichael, may be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Plio. Gregory Jankilevitsch , the sole shareholder of Plio, may also be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Plio. The shares owned by Plio do not include the 10,228,079 shares of the issuer's Common Stock held by Chione Limited, which has the same directors as Plio. Each reporting person states that neither the filing of this Form 4 nor anything herein shall be deemed an admission that such person or any other person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or otherwise, the beneficial owner of any securities covered by this Form 4. Beneficial ownership of the securities covered by this statement is disclaimed, except, with respect to any person, to the extent of the pecuniary interest of such person in such securities. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this Form 4 nor anything herein shall be construed as an admission that such person or any other person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer. Exhibit Index Exhibit 24.1 - Power of Attorney, dated November 5, 2013, made by Marcin Czernik and Plio Limited in favor of Simon Prisk (previously filed) Exhibit 24.2 - Power of Attorney, dated November 5, 2013, made by Andreas Hadjimichael and Plio Limited in favor of Simon Prisk (previously filed) Exhibit 24.3 - Power of Attorney, dated November 5, 2013, made by Amalia Hadjimichael and Plio Limited in favor of Simon Prisk (previously filed) Exhibit 99.1 - Joint Filer Information (filed herewith) Exhibit 99.2 - Joint Filing Agreement (previously filed) All previously filed Exhibits were filed with the Form 3 of the reporting persons, Plio Limited and Gregory Jankilevitsch, filed on November 8, 2013. Marcin Czernik, by /s/ Simon Prisk, as attorney-in fact by power of attorney 2014-08-28 /s/ Andreas Hadjimichael, by /s/ Simon Prisk, as attorney-in fact by power of attorney 2014-08-28 /s/ Amalia Hadjimichael, by /s/ Simon Prisk, as attorney-in fact by power of attorney 2014-08-28 EX-99.1 2 f4082514ex99iczernik_karyo2.htm JOINT FILER INFORMATION

Exhibit 99.1

 

Joint Filer Information

 

(Other Reporting Persons)

 

Name:

Andreas Hadjimichael 

   
Address:

Simou Menardou 8

Ria Court 8, Office 101

6015 Larnaca,  Cyprus

   

Designated Filer: 

 Marcin Czernik 
   

Issuer & Ticker Symbol:

Karyopharm Therapeutics Inc. [KPTI] 

Date of Earliest Transaction Required to Be Reported: 

 08/26/2014
   
Relationship of Reporting Persons to Issuer:

10% Owner

   

If Amendment, Date Original Filed (Month/Day/Year):

 Not Applicable
   
Individual or Joint/Group Filing: Form filed by More than One Reporting Person
   
Signature and Date: Andreas Hadjimichael, by /s/ Simon Prisk, as attorney-in fact  by power of attorney 11/5/13

 

Name: Amalia Hadjimichael
   
Address:

Simou Menardou 8

Ria Court 8, Office 101

6015 Larnaca,  Cyprus

   
Designated Filer: Marcin Czernik
   
Issuer & Ticker Symbol: Karyopharm Therapeutics Inc. [KPTI]
   

Date of Earliest Transaction Required to Be Reported:

 

 08/26/2014
Relationship of Reporting Persons to Issuer: 10% Owner
   
If Amendment, Date Original Filed  (Month/Day/Year): Not Applicable
   

Individual or Joint/Group Filing:

Form filed by More than One Reporting Person 

   
Signature and Date: Amalia Hadjimichael, by /s/ Simon Prisk, as attorney-in fact  by power of attorney 11/5/13